Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Christophe De Block
ResearcherPublications, citations & collaboration network
Christophe De Block is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 337 works, 12,231 citations, an h-index of 49 and an i10-index of 138.
337
Works
12,231
Citations
49
h-index
138
i10-index
How has Christophe De Block's publication output changed over time?
ScholarIQpublication output · 2005–2026
Output grew0% over the shown period — from 1 works in 2005 to 1 in 2026.
1
1
1
1
3
1
1
1
1
200520062007201020182019202020222026
What are the most-cited papers on Christophe De Block?
ScholarIQmost cited works
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal, Ilse Mertens, Christophe De Block
Nature. 20062,826 Citations
Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes
Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler, Chantal Mathieu, Leonard Kaufman, G Hale, Frans Gorus, Michel Goldman, Markus Walter, Sophie Candon, Liliane Schandené, Laurent Crenier, Christophe De Block, Jean‐Marie Seigneurin, Pieter De Pauw, Denis Piérard, Ilse Weets, Peppy Rebello, Pru Bird, Eleanor Berrie, Mark R. Frewin, Herman Waldmann, Jean‐François Bach, Daniël Pipeleers, Lucienne Chatenoud
New England Journal of Medicine. 20051,096 CitationsOPEN ACCESS
Autoimmune gastritis
Marco Vincenzo Lenti, Massimo Rugge, Edith Lahner, Emanuela Miceli, Ban‐Hock Toh, Robert M. Genta, Christophe De Block, Chaim Hershko, Antonio Di Sabatino
Nature Reviews Disease Primers. 2020334 Citations
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
Bart Keymeulen, Melanie Walter, Chantal Mathieu, L. Kaufman, Frans Gorus, Robert Hilbrands, Evy Vandemeulebroucke, Ursule Van de Velde, Laurent Crenier, Christophe De Block, Sophie Candon, Herman Waldmann, A G Ziegler, Lucienne Chatenoud, Daniël Pipeleers
Diabetologia. 2010313 CitationsOPEN ACCESS
Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study
Sara Charleer, Christophe De Block, Liesbeth Van Huffel, Ben Ayed B, Steffen Fieuws, Frank Nobels, Chantal Mathieu, Pieter Gillard
Diabetes Care. 2019257 CitationsOPEN ACCESS
Related on ScholarIQ
University of Antwerp
Institution
Mechanisms linking obesity with cardiovascular disease
Paper
Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes
Paper
Autoimmune gastritis
Paper
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
Paper
Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study
Paper